Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v27-FR Version v12-FR
Language French French
Date Updated 2020-11-25 2020-09-25
Drug Identification Number 02377225 02377225
Brand name MOZOBIL MOZOBIL
Common or Proper name Mozobil Mozobil
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients PLERIXAFOR PLERIXAFOR
Strength(s) 20MG 20MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1 x 2.0ml 1 x 2.0ml
ATC code L03AX L03AX
ATC description IMMUNOSTIMULANTS IMMUNOSTIMULANTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2020-12-04
Actual start date 2020-09-25
Estimated end date Unknown Unknown
Actual end date 2020-11-25
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments production/ supply delay - Considering the exceptional circumstances, the remaining stock will be distributed on allocation with a limit of 2 vials per order. Pharmacies are invited to communicate with their preferred distributor to obtain more information on product availability. production/ supply delay - Considering the exceptional circumstances, the remaining stock will be distributed on allocation with a limit of 2 vials per order. Pharmacies are invited to communicate with their preferred distributor to obtain more information on product availability.
Health Canada comments